Clinical Trials Logo

Clinical Trial Summary

Height and weight are important informations in clinical life. Medication is dosed by them and weight, especially overweight, is a risk factor for cardiovascular diseases. Mostly you have to rely on the self-reported informations, because there is plenty of work and little time to weigh and measure every patient. But can the investigators really trust this informations? Former studies have shown, that most of self-reported heights and weights differ from the measured ones. This fact might lead to a wrong dosage of medicine or underestimated risk factors. So the Cardial-MASS-Study tries to detect influencing factors on the reliability of self-reported informations especially among patients, treated at the cardiological department at Saarland University.


Clinical Trial Description

Weight and height of patients is often recorded in clinical practice, as well as in clinical research. They give important informations for medication dosages, e.g., anticoagulants or anesthesias. Furthermore, the body mass index (BMI), calculated by weight and height, is an easy instrument to estimate a patient`s risk for cardiovascular diseases based on obesity.

In clinical practice, informations about height and weight do often rely on self-reported values instead of measured ones. This can be due to limited timely, but also instrumental resources, when scales or measuring tapes are not available. Unfortunately, these self-reported informations are often inaccurate. Age, education, weight, and sex seam to influence and distort them in different ways.

Former studies have shown, that a lot of patients overestimate their height [1-8] and underestimate their weight [1-6]. This might lead to a wrong classification in normal weight and overweight using BMI. Among elderly (>60 years) informations relying on measured values and on self-reported values seem to be even more divergent [10].

People with overweight are tending to underestimate their weight stronger than people with normal weight. The higher the weight, the more the self-reported information deviates from the actual weight [11,12]. Men`s informations are more exact than women`s, like Niedhammer et al. has shown in a study with 7350 participants [9]. Men with a BMI lower than 25 even overestimated their weight. Compared to younger ones, elderly men underestimated their weight more often, and elderly women`s self-reported weight was more accurate [1,9].

Next to age and gender, socioeconomic variables do influence self-reported measures. The higher the education or working position the more accurate the information about height. Noteworthy, women in high working positions overestimate their height, when compared to women in lower positions, who even underestimate their height [2,5,6,8,9].

Furthermore, external conditions of data acquisition may impact validity of self-reported information, too. Stewart supposed that informations given in an interview are more exact than those given in a questionnaire [11].

Most of the studies mentioned above are not exclusively related to patients with cardiovascular diseases. Studies referring to this patient population suggest, that men with cardiovascular diseases underestimate their weight less than others [13]. Nevertheless, Niedhammer et al. could not confirm this finding [9]. HEnce, the aim of this study is to identify factors that influence the validity of self-reported height and weight in patients with cardiovascular disease. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04321057
Study type Observational
Source Saarland University
Contact
Status Active, not recruiting
Phase
Start date April 1, 2017
Completion date June 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)